SGLT-2 Inhibition Beyond Glycemic Control: Exploring the Neuroprotective Properties of Dapagliflozin in Diabetes-Related Neurodegeneration . Cuestiones de Fisioterapia, [S. l.], v. 53, n. 03, p. 6207–6213, 2024. DOI: 10.48047/mbw59m89. Disponível em: https://cuestionesdefisioterapia.com/index.php/es/article/view/3770.. Acesso em: 13 jun. 2026.